Israeli medical device company NLT SPINE opens new U.S. office in Dedham, Massachusetts

March 12, 2013

DEDHAM, Mass. – March 12, 2013 – NLT SPINE, an Israeli developer of Minimally Invasive Spine Surgery (MISS) products, and the Massachusetts Life Sciences Center (MLSC) today announced the opening of the company’s first U.S. subsidiary located in temporary office space in Dedham, Mass. The new office will support the commercialization of its advanced technology platform. NLT SPINE is based in Kfar Saba, Israel.

NLT Spine is the third Israeli medical device company to announce plans to locate an office or subsidiary in Massachusetts since the Governor’s trade mission to Israel in 2011.

“Establishing the U.S. base of operations in Massachusetts was an easy decision for us,” said Tom Keegan, Vice President of Business Development and U.S. Marketing for NLT SPINE. “It is an area that is rich with expertise in the life sciences. Logistically, it works well for travel in and out of the U.S. for NLT SPINE employees from Israel, and it is an excellent hub for convenient access to the rest of the country.”

NLT SPINE plans to hire up to three employees in Massachusetts by the end of 2013. The company expects to hire eight to 10 additional employees in Massachusetts, and 10 to 15 independent sales representatives across the U.S. during 2014.

“Our vision is ultimately to revolutionize the spine market and create a shift towards MISS, similar to the way the catheter has revolutionized cardiovascular procedures,” said Didier Toubia, CEO, NLT SPINE. “We are very pleased with the positive results from recent clinical experience and we look forward to bringing additional benefits to surgeons and hospitals in the U.S.”

NLT SPINE specializes in the development and marketing of innovative MISS products for treating degenerative spinal conditions. Following the initial positive results from clinical experience with its PROW FUSIONTM intervertebral body fusion device and the eSPINTM discectomy tool, backed by its strong IP portfolio, NLT SPINE is preparing for the commercialization of its platform in the U.S. market.

NLT SPINE was recently awarded and named “one of the 10 most promising start-up firms of 2012” by The Globes, a leading news source for business, finance and technology in Israel. The company was selected for its unique innovation and wide potential applicability of its non-linear technology platform.

Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008.

“On behalf of the Center, I would like to extend our warmest congratulations to the team at NLT SPINE as they open their first U.S. office here in Massachusetts,” said Susan Windham-Bannister, Ph.D., President & CEO of the MLSC. “Medical devices are the Commonwealth’s number-one export, and the state has more than 400 device companies that will provide a welcoming environment for NLT SPINE to expand and do business. We look forward to collaborating with NLT SPINE as they pursue better treatments for degenerative spinal conditions, and I am pleased to welcome the company to the Massachusetts life sciences community.”

“The investments in life sciences that the Commonwealth has provided have made a big impact in keeping our state ahead of the curve when it comes to jobs and the economy,” said State Senator Mike Rush. “I commend NLT SPINE for choosing Dedham and recognizing that the town is a great place to work and to live.”

“I enthusiastically welcome the first in the nation office of NLT SPINE and applaud their commitment to Massachusetts for their innovation, technology and advancement to spinal patients,” said State Representative Paul McMurtry.

“NLT SPINE will join a broad and deep ecosystem in the global hub of life sciences,” said Tom Gradel, Manager of Business Development and Protocol Officer at the Massachusetts Office of International Trade & Investment.

“Like many other overseas medtech companies, NLT SPINE has found that Massachusetts is the perfect location for establishing a presence in the U.S.,” said Tom Sommer, President of the Massachusetts Medical Device Industry Council (MassMEDIC). “Our state offers unparalleled access to world-class medical research, a talented workforce and a vibrant supply-base able to meet the needs of growing medical technology companies.”

NLT SPINE’s new U.S. office is based at:
990 Washington Street
Suite 204
Dedham, MA 02026

NLT SPINE specializes in the development of innovative spine surgery instrumentation and implants for treating degenerative spinal conditions through small surgical incisions. The company’s vision is to improve patient care and reduce total treatment costs by ultimately shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance usability and outcomes.
Led by top international leaders in spinal surgery, NLT SPINE holds a wide portfolio of pending and issued patents that cover the non-linear core technology and related implant and instrument technologies. For more information about the company, visit

About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a 10-year, $1-billion initiative that was signed into law in June of 2008. The MLSC’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. For more information, visit

Media Contacts:
Tom Keegan
Vice President Business Development and US Marketing
+1 508 272 7750

Massachusetts Life Sciences Center:
Angus McQuilken
Vice President for Communications and Marketing
+1 617 921 7749

This announcement is not intended to be a commercial endorsement by the MLSC of any products or services provided or developed by the entities referenced in this release.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.